CureTech Ltd.
Records under this name other than the patents CureTech Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 9 of 9 · Back to CureTech Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,747,847 | Monoclonal antibodies for tumor treatment Lapsed on the fee record Ended Jun 10, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 10, 2026 | From the USPTO record |
| US 8,686,119 | Variants of humanized immunomodulatory monoclonal antibodies Lapsed on the fee record Ended Apr 1, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 1, 2026 | From the USPTO record |
| US 9,580,504 | Pidilizumab monoclonal antibody therapy following stem cell transplantation Lapsed on the fee record Ended Feb 28, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 28, 2025 | From the USPTO record |
| US 7,981,416 | Humanized Immunomodulatory Monoclonal Antibodies for the Treatment of Immunodeficiency Term ended Term ended Mar 14, 2024 · High confidence | Term ended | Term ended Mar 14, 2024 | High confidence |
| US 7,332,582 | Humanized Immunomodulatory Monoclonal Antibodies for the Treatment of Neoplastic Disease or Immunodeficiency Formerly held Term ended Term ended May 22, 2023 · High confidence | Term ended | Term ended May 22, 2023 | High confidence |
| US 7,524,498 | Human Immunomodulatory Monoclonal Antibodies for the Treatment of Cancer Term ended Term ended May 22, 2023 · High confidence | Term ended | Term ended May 22, 2023 | High confidence |
| US 7,122,372 | Peptide Useful in Immunomodulation Term ended Term ended Feb 25, 2023 · High confidence | Term ended | Term ended Feb 25, 2023 | High confidence |
| US 7,745,397 | Peptide Useful in Immunomodulation Lapsed on the fee record Ended Jun 29, 2022 · Medium confidence | Lapsed on the fee record | Ended Jun 29, 2022 | Medium confidence |
| US 7,329,639 | Peptide Useful in Immunomodulation Lapsed on the fee record Ended Feb 12, 2020 · High confidence | Lapsed on the fee record | Ended Feb 12, 2020 | High confidence |